Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)
Authors
Bischoff, H.Garassino, M. C.
Mazieres, J.
Reck, M.
Chouaid, C.
Cove-Smith, Laura
Mansy, T.
Migliorino, M. R.
Delmonte, A.
Sanchez, J. G.
Velarde, L. E. C.
Bernabe, R.
Paz-Ares, L.
Perez, I. D.
Trunova, N.
Foroutanpour, K.
Faivre-Finn, Corinne
Reinmuth, N.
Affiliation
Thoraxklinik, Heidelberg, DeutschlandIssue Date
2022